Crilanomer

Crilanomer is a pharmaceutical drug used in the treatment of hyperkalemia, a condition characterized by high levels of potassium in the blood. It is a cation exchange resin that works by binding to potassium ions in the gastrointestinal tract, thereby reducing their absorption into the bloodstream.

Mechanism of Action

Crilanomer's primary mechanism of action involves the exchange of sodium ions for potassium ions in the gastrointestinal tract. This exchange process reduces the overall concentration of potassium in the body, thereby helping to manage hyperkalemia.

Uses

Crilanomer is primarily used in the treatment of hyperkalemia. It may be used in conjunction with other treatments, such as dietary changes and medication, to manage this condition.

Side Effects

Like all medications, Crilanomer can cause side effects. These may include nausea, vomiting, and abdominal pain. In rare cases, it may cause serious side effects such as intestinal obstruction.

Contraindications

Crilanomer should not be used in patients with a history of hypersensitivity to the drug. It is also contraindicated in patients with obstructive bowel disease or intestinal perforation.

Interactions

Crilanomer may interact with other medications, including heart medications and blood pressure medications. It is important for patients to inform their healthcare provider of all medications they are currently taking.

See Also

• Hyperkalemia
• Cation exchange resin
• Pharmaceutical drug

‎